Trials / Unknown
UnknownNCT06202430
Ultrasound Guided Block for Postoperative Analgesia in Arthroscopic Shoulder Surgery
Comparison of Ultrasound Guided High Thoracic Erector Spinae Plane Block With Shoulder Block for Postoperative Analgesia in Arthroscopic Shoulder Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study aimed to compare the efficacy of high thoracic-ESPB with shoulder block as analgesic options for arthroscopic shoulder surgery. Primary outcome: • 24-hour analgesic consumption. Secondary outcomes: * Postoperative pain evaluated by: Visual Analogue Pain Scale (VAS). * Time to first rescue analgesia and total postoperative consumption of analgesia. * Effect of the block on Hemodynamics. * Adverse effects in the form of postoperative nausea and vomiting (PONV). * Patient satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | High Thoracic Erector Spinae Plane Block | High Thoracic-ESPB The patient was placed in the lateral decubitus. The transverse process of T2 was identified. After negative aspiration, hydro dissection using 2 mL of saline was performed. Eventually, 30 mL of the LA bupivacaine 0.25% and epinephrine 5 µg/ mL was injected. |
| PROCEDURE | Shoulder Block | Shoulder Block Suprascapular nerve block (SSNB) approach: The needle was progressed in plane from medial to lateral after local infiltration of the skin with 1% lidocaine. We directed the needle towards the lateral side of the supra-spinous fossa if the neuro-vascular bundle was not evident. After careful aspiration, 10 ml of 0.5% bupivacaine was injected under the supraspinatus muscle. Axillary nerve block technique: The nerve approach had been described in plane from cranial to caudal. After local infiltration of the skin with 1% lidocaine, the needle tip must be visualized within the fascia below the teres minor muscle and just above the PCHA. After cautious aspiration, 10 ml of 0.5% bupivacaine was injected on the posterior aspect of the humerus. |
Timeline
- Start date
- 2023-08-13
- Primary completion
- 2024-01-14
- Completion
- 2024-01-14
- First posted
- 2024-01-11
- Last updated
- 2024-01-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06202430. Inclusion in this directory is not an endorsement.